NCT03976882 2025-05-16Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.Jiangsu HengRui Medicine Co., Ltd.Phase 3 Completed129 enrolled
NCT05261646 2023-09-28A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced ThrombocytopeniaJiangsu HengRui Medicine Co., Ltd.Phase 3 Withdrawn